Predictors and Impact of Thirty-Day Readmission on Patient Outcomes and Health Care Costs after Reduced-Toxicity Conditioning Allogeneic Hematopoietic Cell Transplantation

Thirty-day readmission (30-DR) has become an important quality-of-care measure. Allogeneic hematopoietic cell transplantation (allo-HCT) presents a medical setting with higher readmission rates. We analyzed factors affecting 30-DR and its impact on patient outcomes and on health care costs in 91 pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Rauenzahn, Sherri, Truong, Quoc, Cumpston, Aaron, Goff, Londia, Leadmon, Sonia, Evans, Kim, Zhang, Jianjun, Wen, Sijin, Craig, Michael, Hamadani, Mehdi, Kanate, Abraham S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4557764/
https://ncbi.nlm.nih.gov/pubmed/24361913
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2013.12.559
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados